Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TRIM14 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | increases expression | ISO | Trim14 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of TRIM14 mRNA | CTD | PMID:22206623 | 1,3-dinitrobenzene | affects expression | EXP | | 6480464 | 3-dinitrobenzene affects the expression of TRIM14 mRNA | CTD | PMID:24140754 | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of TRIM14 mRNA | CTD | PMID:21983209 | 17beta-estradiol | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TRIM14 mRNA | CTD | PMID:19619570 | 17beta-estradiol | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Estradiol results in increased expression of TRIM14 mRNA | CTD | PMID:19619570 more ... | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Trim14 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TRIM14 mRNA | CTD | PMID:19619570 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRIM14 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Trim14 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TRIM14 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TRIM14 mRNA | CTD | PMID:16704738 and PMID:21296121 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TRIM14 mRNA | CTD | PMID:19619570 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of TRIM14 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of TRIM14 mRNA | CTD | PMID:30851411 | 4,4'-sulfonyldiphenol | increases expression | ISO | Trim14 (Mus musculus) | 6480464 | bisphenol S results in increased expression of TRIM14 mRNA | CTD | PMID:30951980 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of TRIM14 mRNA | CTD | PMID:24780913 | all-trans-retinoic acid | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of TRIM14 mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of TRIM14 mRNA | CTD | PMID:33167477 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of TRIM14 mRNA | CTD | PMID:30779732 | antirheumatic drug | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of TRIM14 mRNA | CTD | PMID:24449571 | arsenous acid | increases expression | ISO | Trim14 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of TRIM14 mRNA | CTD | PMID:35676786 | benzo[a]pyrene | increases methylation | ISO | TRIM14 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of TRIM14 3' UTR | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of TRIM14 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TRIM14 mRNA | CTD | PMID:34947998 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TRIM14 mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of TRIM14 gene | CTD | PMID:28505145 | bisphenol F | increases expression | ISO | Trim14 (Mus musculus) | 6480464 | bisphenol F results in increased expression of TRIM14 mRNA | CTD | PMID:30951980 | butanal | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of TRIM14 mRNA | CTD | PMID:26079696 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of TRIM14 mRNA | CTD | PMID:19167457 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of TRIM14 promoter | CTD | PMID:22457795 | carbon nanotube | decreases expression | ISO | Trim14 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of TRIM14 mRNA | CTD | PMID:25620056 | carbon nanotube | increases expression | ISO | Trim14 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to TRIM14 gene] | CTD | PMID:28238834 | cobalt dichloride | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of TRIM14 mRNA | CTD | PMID:19376846 | copper atom | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of TRIM14 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of TRIM14 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of TRIM14 mRNA | CTD | PMID:19549813 | CU-O LINKAGE | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of TRIM14 mRNA | CTD | PMID:22077320 | cyclosporin A | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of TRIM14 mRNA | CTD | PMID:25562108 | diarsenic trioxide | increases expression | ISO | Trim14 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of TRIM14 mRNA | CTD | PMID:35676786 | dicrotophos | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of TRIM14 mRNA | CTD | PMID:28302478 | dioxygen | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of TRIM14 mRNA | CTD | PMID:26516004 | dioxygen | multiple interactions | ISO | Trim14 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRIM14 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of TRIM14 mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of TRIM14 mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | entinostat results in increased expression of TRIM14 mRNA | CTD | PMID:26272509 and PMID:27188386 | entinostat | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM14 mRNA | CTD | PMID:27188386 | folic acid | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of TRIM14 mRNA | CTD | PMID:21867686 | formaldehyde | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of TRIM14 mRNA | CTD | PMID:23649840 | glafenine | decreases expression | EXP | | 6480464 | Glafenine results in decreased expression of TRIM14 mRNA | CTD | PMID:24136188 | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of TRIM14 mRNA | CTD | PMID:24915197 | hydrogen peroxide | affects expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of TRIM14 mRNA | CTD | PMID:20044591 | lipopolysaccharide | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIM14 mRNA | CTD | PMID:35811015 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of TRIM14 mRNA | CTD | PMID:28801915 | menadione | affects expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of TRIM14 mRNA | CTD | PMID:20044591 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of TRIM14 mRNA | CTD | PMID:30467583 | methyl methanesulfonate | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of TRIM14 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of TRIM14 mRNA | CTD | PMID:23179753 | methylseleninic acid | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | methylselenic acid results in decreased expression of TRIM14 mRNA | CTD | PMID:18548127 | nickel atom | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Nickel results in increased expression of TRIM14 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | multiple interactions | ISO | Trim14 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TRIM14 mRNA | CTD | PMID:34911549 | panobinostat | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM14 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | panobinostat results in increased expression of TRIM14 mRNA | CTD | PMID:26272509 | paracetamol | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of TRIM14 mRNA | CTD | PMID:21420995 and PMID:29067470 | parathion | decreases expression | ISO | Trim14 (Mus musculus) | 6480464 | Parathion results in decreased expression of TRIM14 mRNA | CTD | PMID:34813904 | phenobarbital | affects expression | ISO | Trim14 (Mus musculus) | 6480464 | Phenobarbital affects the expression of TRIM14 mRNA | CTD | PMID:23091169 | phenylmercury acetate | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of TRIM14 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRIM14 mRNA | CTD | PMID:27188386 | potassium chromate | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of TRIM14 mRNA | CTD | PMID:22714537 | rac-lactic acid | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of TRIM14 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of TRIM14 mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIM14 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | tamoxifen | decreases expression | ISO | Trim14 (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of TRIM14 mRNA | CTD | PMID:25123088 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TRIM14 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of TRIM14 mRNA | CTD | PMID:31150632 | thimerosal | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of TRIM14 mRNA | CTD | PMID:27188386 | trichostatin A | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of TRIM14 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM14 mRNA | CTD | PMID:27188386 | triclosan | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of TRIM14 mRNA | CTD | PMID:30510588 | triptonide | increases expression | ISO | Trim14 (Mus musculus) | 6480464 | triptonide results in increased expression of TRIM14 mRNA | CTD | PMID:33045310 | urethane | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Urethane results in decreased expression of TRIM14 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TRIM14 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM14 mRNA | CTD | PMID:27188386 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of TRIM14 mRNA | CTD | PMID:23034163 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of TRIM14 gene | CTD | PMID:31079544 | vitamin E | decreases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of TRIM14 mRNA | CTD | PMID:19244175 | vorinostat | multiple interactions | ISO | TRIM14 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM14 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | TRIM14 (Homo sapiens) | 6480464 | vorinostat results in increased expression of TRIM14 mRNA | CTD | PMID:26272509 | |